Optimized Protocol for F-18-Choline PET/CT in Patients with Biochemically Relapsed Prostate Cancer Experiences on 250 Consecutive Cases

Chondrogiannis Sotirios; Marzola Maria Cristina; Grassetto Gaia; Rampin Lucia; Massaro Arianna; Colletti Patrick M.; Rubello Domenico

首页> 外文期刊>Clinical nuclear medicine >Optimized Protocol for F-18-Choline PET/CT in Patients with Biochemically Relapsed Prostate Cancer Experiences on 250 Consecutive Cases

【24h】

Optimized Protocol for F-18-Choline PET/CT in Patients with Biochemically Relapsed Prostate Cancer Experiences on 250 Consecutive Cases

机译：250例连续性生化复发前列腺癌患者的F-18-胆碱PET / CT优化方案

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: We reviewacquisition F-18-choline PET/CT methodology, evaluate a new F-18-choline acquisition protocol for prostate cancer (PC), and propose a standardized acquisition protocol on F-18-choline in PC patients.

机译：目的：我们审查F-18胆碱PET / CT方法的获取，评估前列腺癌（PC）的新F-18胆碱采集方案，并提出PC患者F-18胆碱的标准化采集方案。

著录项

来源
《Clinical nuclear medicine 》 |2015年第6期| 共5页
作者
Chondrogiannis Sotirios; Marzola Maria Cristina; Grassetto Gaia; Rampin Lucia; Massaro Arianna; Colletti Patrick M.; Rubello Domenico;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学 ;
关键词
F-18-Choline; prostate cancer; early imaging; acquisition protocol;

机译：F-18-胆碱;前列腺癌;早期成像;采集方案;

相似文献

外文文献
中文文献
专利

1. Optimized Protocol for F-18-Choline PET/CT in Patients with Biochemically Relapsed Prostate Cancer Experiences on 250 Consecutive Cases [J] . Chondrogiannis Sotirios, Marzola Maria Cristina, Grassetto Gaia, Clinical nuclear medicine . 2015 ,第6期

机译：250例连续性生化复发前列腺癌患者的F-18-胆碱PET / CT优化方案
2. Gleason Score at Diagnosis Predicts the Rate of Detection of F-18-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients (vol 56, pg 209, 2015) [J] . Cimitan The Journal of Nuclear Medicine . 2015 ,第6期

机译：诊断时的格里森评分可预测当生化证据表明前列腺癌复发时进行F-18-胆碱PET / CT的检出率：约有1000名患者的经验（第56卷，第209页，2015年）
3. Gleason Score at Diagnosis Predicts the Rate of Detection of F-18-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients [J] . Cimitan Marino, Evangelista Laura, Hodolic Marina, The Journal of Nuclear Medicine . 2015 ,第2期

机译：诊断时的格里森评分可预测当生化证据表明前列腺癌复发时进行F-18-胆碱PET / CT的检出率：有1000名患者的经验
4. Digital Transformation of Prostate Cancer Pathway and Optimizing Patient Experience, Patient Safety and Clinical Professionalism [C] . Joan Cahill, Ben Turney, Sean Wetherall, International Conference on Digital Human Modeling and Applications in Health, Safety, Ergonomics and Risk Management;International Conference on Human-Computer Interaction . 2019

机译：前列腺癌途径的数字化转型，优化患者体验，患者安全性和临床专业性
5. Development of an immuno-mass spectrometric assay for validation of protein C inhibitor (PCI) as a biomarker for prediction of biochemical recurrence in prostate cancer patients [D] . Razavi, Morteza 2012

机译：开发一种用于鉴定蛋白C抑制剂（PCI）作为预测前列腺癌患者生化复发的生物标记物的免疫质谱法
6. Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients [O] . Wouter Huysse, Frédéric Lecouvet, Paolo Castellucci, 2017

机译：F-18胆碱PET / CT扫描与轴向MRI在生化复发前列腺癌患者中检测骨转移的前瞻性比较
7. Impact of \(^{68}\)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy [O] . Bluemel, Christina, Linke, Fraenze, Herrmann, Ken, 2017

机译：\（^ {68} \）Ga-PSMA PET / CT对前列腺癌术后前列腺切除术持续PSA值或生化复发的挽救性放疗计划的影响
8. Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Biochemically Monoclonal Antibody J591 in Patients with High-Risk Castrate, Biochemically Relapsed Prostate Cancer [R] . Tagawa, S. T. 2010

机译：177Lu放射性标记的抗psma生化单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验

Optimized Protocol for F-18-Choline PET/CT in Patients with Biochemically Relapsed Prostate Cancer Experiences on 250 Consecutive Cases

摘要

著录项

相似文献

相关主题

期刊订阅